Arkolith/Insider Trading/QNCX/Form 4

Lamond David

DirectorQuince Therapeutics, Inc. (QNCX) · full profile →Form 4 · filed Dec 1, 2023
Net Buying
Open-Market Buys
$41K
Open-Market Sells
$0
Net Open-Market Flow
$41K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2023Buy(P)14K$0.94$14K2.2M
Nov 30, 2023Buy(P)14K$0.90$13K2.2M
Nov 29, 2023Buy(P)14K$0.98$14K2.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML